Vaccines with enhanced immune response and methods for their preparation

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

DNA vaccine

DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a)

Yeast-based therapeutic for chronic hepatitis B infection

MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES

PROCESS FOR PRODUCING AN IMMUNOGENIC COMPOSITION CONTAINING TETANUS TOXOID

Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

Controlled activation of complement components for use as endogenous adjuvant

YEAST-BASED VACCINES AS IMMUNOTHERAPY

COMPOSITIONS INCLUDING TRANSFER FACTOR DERIVED FROM EGGS

Vaccine for inducing an improved immune reaction

VACCINE COMPOSITION

Vaccine delivery method

Immunogenic composition

INDUCTION OF IMMUNE RESPONSE

Immunostimulating Polyphosphazene Compounds

ADJUVANTED VACCINES FOR SEROGROUP B MENINGOCOCCUS

YEAST-BASED VACCINES AS IMMUNOTHERAPY

METHOD OF VACCINATION

Composition for treating HBV infection

Process for manufacturing vaccines

HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS

FORMULATION OF HEPATITIS B VIRUS ANTIGENS FOR CELLULAR STIMULATION FOLLOWED BY THERAPEUTIC IMMUNIZATION

Methods and compositions for eliciting an immune response against hepatitis B virus

IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME

Composition for treating HBV infection

Chimeric immunomodulatory compounds and methods of using the same-IV

Formulation of drugs and vaccines in the form of percutaneous injectable needles

Adjuvanted vaccine formulations

Vaccine composition

Formulation of immunopotentiators

Methods for preparing vesicles and formulations produced therefrom

Chimeric therapeutics, compositions, and methods for using same

Method to enhance an immune response of nucleic acid vaccination

Multivalent nanoemulsion vaccines

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

Method of storing a vaccine containing an aluminum adjuvant

THERMOSENSITIVE HEPATITIS B VACCINE

Compositions and methods that enhance an immune response

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

Immunogen platform

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles

Compositions and methods for identifying antigens which elicit an immune response

COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF HBV INFECTIONS AND HBV-MEDIATED DISEASES

Vaccine Composition

Combination vaccine with acellular pertussis

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

Antigenic compositions and use of same in the targeted delivery of nucleic acids

HBV vaccine and a process of preparing the same

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

Immunogen platform

Fusion proteins and use thereof for preparing hepatitis C vaccines

Yeast-based vaccines as immunotherapy

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR

METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN

T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen

LASER-BASED VACCINE ADJUVANTS

Stabilisation of Proteins

NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS

Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors

Vaccine Against Streptococcus Pneumoniae

Immuniostimulating polyphosphazene compounds

Vaccine formulation potentiated by the combination of DNA and an antigen

EXPRESSION CASSETTE, T-DNA MOLECULE, PLANT EXPRESSION VECTOR, TRANSGENIC PLANT CELL AS WELL AS THEIR USE IN THE MANUFACTURING OF A VACCINE

Immunotherapy and prevention of autoimmune hepatitis

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

HYDROGELS FOR COMBINATORIAL DELIVERY OF IMMUNE-MODULATING BIOMOLECULES

Nucleic acids encoding antibodies or portions thereof comprising a heterologous T cell epitope and their use in modulating T cell responses

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

Process for manufacturing vaccines

COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES

Vaccines Containing Non-Live Antigenic Vectors

STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE

Organic Compounds

Immunostimulatory oligonucleotides

TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME

IMMUNOGENIC MOLECULES

POLYMER PARTICLES BASED VACCINE

Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides

Method to enhance an immune response of nucleic acid vaccination

VACCINE

Optimized multi-epitope constructs and uses thereof

Enhancing of hepatitis B virus vaccine and its gene

Method and System for Optimizing Minigenes and Peptides Encoded Thereby

Inactivated polio vaccines

Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production

Vaccine

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

Processes for treating subjects carrying viral infectious agent

Chimeric immunomodulatory compounds and methods of using the same-II

NANOEMULSION ADJUVANTS

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

Immunogenic composition

VIRUS LIKE PARTICLES

IMMUNOGEN PLATFORM

Combination vaccines with whole cell pertussis antigen

MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION

METHOD FOR ENHANCING THE EFFICACY OF ANTIGEN SPECIFIC TUMOR IMMUNOTHERAPY

Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

METHOD FOR TREATING TUMOR USING IRRADIATED TUMOR CELL EXPRESSING HUMAN HEPATITIS B SURFACE ANTIGEN AND A PHARMACEUTICAL COMPOSITION COMPRISING THE TUMOR CELL

Immunogenic composition

Stable vaccine formulation

Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations

Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis

Vaccines with enhanced immune response and methods for their preparation

Virosome particles comprising antigens from influenza virus and hepatitis b virus

METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES

Vaccines with enhanced immune response and methods for their preparation

Immunomodulator Compounds as Vaccine Enhancers

Immunogen platform

Immunogenic composition

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

Advanced genetic vaccines

Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines

Anti-malaria vaccine

Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

Compositions for inducing an immune response against hepatitis B

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof

Immunogenic composition

Immunogenic composition

Chimeric immunomodulatory compounds and methods of using the same

Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use

OIL IN WATER EMULSIONS CONTAINING SAPONINS

Methods of inducing mucosal immunity

Vaccine Composition Against Hepatitis C Virus

Compositions and methods for identifying antigens which elicit an immune response

Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo

Methods to bypass CD4+ cells in the induction of an immune response

Novel Composition

Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

VACCINE COMPOSITION

Liquids Containing Suspended Glass Particles

HBV core antigen particles with multiple immunogenic components attached via peptide ligands

Pharmaceutical Compositions for Therapeutic Use

IRIDOID GLYCOSIDE COMPOSITION

Method of treating and preventing infectious diseases

Immunomodulating compositions and uses therefor

Antigens encoded by alternative reading frames from pathogenic viruses

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

Injectable vaccines against multiple meningococcal serogroups

Chimeric immunomodulatory compounds and methods of using the same—IV

Optimized multi-epitope constructs and uses thereof

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses

Influenza immunogen and vaccine

Method

Methods for genetic immunization

Stabilized immunogenic HBc chimer particles

Minimal promoters and uses thereof

Methods and compositions for inducing antigen-specific immune responses

Composition

Vaccines

HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof

Packaged virus-like particles

Vaccines

Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases

Oral DNA composition for hepatitis B virus chronic infection

Compositions and methods for delivery of genetic material

Method for isolating hepatitis C virus peptides

Immunostimulating polyphosphazene compounds

Vaccines containing ribavirin and methods of use thereof

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

Composition for vaccination

Regulated bacterial lysis for gene vaccine vector delivery and antigen release

Viruses and virus-like particles for multiple antigen and target display

Influenza immunogen and vaccine

Adenovirus vectors for immunotherapy

Stabilization of alum-adjuvanted immunologically active agents

Vaccine against Streptococcus pneumoniae

Methods for tailoring the immune response to an antigen or immunogen

Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor

Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor

Novel therapeutic processes for treating cancer with specific antigens

Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor

Novel therapeutic processes for enhancing immunized states of vaccinated subjects

Vaccines expressed in plants

Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

Method to enhance an immune response of nucleic acid vaccination

Vaccines containing a saponin and a sterol

Combination therapies with L-FMAU for the treatment of hepatitis B virus infection

Modified CpG oligodeoxynucleotide with improved immunoregulatory function

Hepatitis B virus treatment

Therapeutic processes and useful compositions therefor

Novel therapeutic vaccination processes, and useful compositions therefor

Combined dna/protein vaccine compositions

Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein

Vaccine against HBV and HPV

Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor

Ultrasound assisted transdermal vaccine delivery method and system

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

Human hepatoma lines, methods for obtaining same and uses thereof

Methods for particle-assisted polynucleotide immunization using a pulsed electric field

Method of treating viral infections

Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

Nucleotide vector vaccine for immunization against hepatitis

Vectors and methods for immunization or therapeutic protocols

Modified viral particles with immunogenic properties and reduced lipid content

Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof

Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations

Vaccines with enhanced immune response and methods for their preparation

Transient expression of biologic materials